“Rooted in Trust. Growing for Tomorrow.”
Taipei, Taiwan, City Thirty Three (formerly Terminal Five)
Founded as a state-subsidized enterprise in the Q3 of 2021, Tian Cheng is an advancing start-up headquartered in City Thirty Three’s agri-industrial commercial sector, with a focus on the intersection of genetic engineered microbiological processed food production. The corporation has quickly positioned itself as a versatile player with aspirations to grow across South-East Asian commercial markets, competing against the larger Tenzhen Industries.
Recently, Tian Cheng has declared their interest in the semi-open markets of Industrial-24 in Geneva, announcing the need for personal market expansion while probing the prospects for raw materials in the greater Geneva area, namely that of Gypsum. Though their investors remain deliberately undisclosed to the public, the corporation benefits from strong financial support from their illusive backers to successfully compete in a rapid, competitive growing market.
Tian Cheng is publicly listed on the FIMEX-24 Stock Exchange under the symbol TIAN. Its intent to grow from a regional upstart into a dominant player in food innovation is evidently clear, yet their true motivations are somewhat unfounded to the public eye.
Sasmita Pharmaceuticals Limited., is Tian Cheng's pharmaceutical subsidiary company based in City 29, Singapore. It focuses its commerce on commercial clinical supplies available to various City markets, in which it attempts to capitalize on. Sasmita primarily employs the Indonesian diaspora within Singapore, and focuses heavily on recruiting the ethnic dispersion, with it's current Executive Board inclusively made up of ethnic Sundanese and Javanese Indonesians.
Founded as a state-subsidized enterprise in the Q3 of 2021, Tian Cheng is an advancing start-up headquartered in City Thirty Three’s agri-industrial commercial sector, with a focus on the intersection of genetic engineered microbiological processed food production. The corporation has quickly positioned itself as a versatile player with aspirations to grow across South-East Asian commercial markets, competing against the larger Tenzhen Industries.
Recently, Tian Cheng has declared their interest in the semi-open markets of Industrial-24 in Geneva, announcing the need for personal market expansion while probing the prospects for raw materials in the greater Geneva area, namely that of Gypsum. Though their investors remain deliberately undisclosed to the public, the corporation benefits from strong financial support from their illusive backers to successfully compete in a rapid, competitive growing market.
Tian Cheng is publicly listed on the FIMEX-24 Stock Exchange under the symbol TIAN. Its intent to grow from a regional upstart into a dominant player in food innovation is evidently clear, yet their true motivations are somewhat unfounded to the public eye.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
